Star Health
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Star Health's recent strategic pivot towards a technology-led distribution model is a significant development, as management emphasizes a digital-first approach to capture the under-penetrated health insurance market. This shift, coupled with a robust 19% YoY growth in gross written premiums, positions the company favorably for accelerating revenue growth, supported by a strong focus on new-to-insurance customers. Vista's financial outlook reflects this momentum, projecting improved profitability through expanding margins and disciplined underwriting practices. The anticipated decline in reinsurance costs and ongoing technology-driven efficiencies further bolster the forecast, aligning with Vista's expected upside of approximately 88%. However, potential headwinds such as regulatory changes and rising medical inflation warrant close monitoring. Overall, the Indian health insurance sector's favorable macroeconomic conditions and increasing consumer awareness provide a conducive environment for Star Health's growth trajectory over the next 12-24 months
Why We Like This Stock
- Management's digital-first strategy is expected to enhance customer acquisition and operational efficiency
- Strong growth in gross written premiums indicates robust demand and market expansion potential
- Improving pricing power and disciplined underwriting practices are likely to support margin expansion
Things To Watch Out For
- Regulatory changes could impose additional compliance costs and impact profitability
- Rising medical inflation may pressure margins and consumer spending on insurance
- Increased competition in the health insurance sector could challenge pricing strategies
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 14,021 | 16,101 | 17,825 | 20,457 | 23,309 |
| Profit Before Tax (Cr.) | 1,129 | 862 | 754 | 1,347 | 1,584 |
| PBT Margin | 8.1% | 5.4% | 4.2% | 6.6% | 6.8% |
| Net Profit (Cr.) | 1,048 | 637 | 557 | 997 | 1,172 |
| Earnings Per Share | 17.8 | 10.8 | 9.5 | 16.9 | 19.9 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Kotak Securities | ▲ Buy | 675 | 25-Sep-2026 |
| Jeffries | ► Hold | 725 | 01-Sep-2026 |
| Motilal Oswal | ▲ Buy | 770 | 30-Jul-2026 |
| Nomura | ▲ Buy | 700 | 30-Jul-2026 |
| Emkay Global | ▲ Buy | 650 | 30-Apr-2026 |
| HDFC Securities | ► Add | 545 | 30-Apr-2026 |
Company Overview
Show Company Profile
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals and families; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments. In addition, it offers star health assure insurance policy, star cancer care platinum insurance policy, senior citizens health insurance policy, and star cardiac care insurance policy platinum, as well as star group OPD care insurance product. The company offers its products through web aggregators, digital channels, agency channels, corporate agents, brokers, point of salesperson, insurance marketing firms, and various other channels. Star Health and Allied Insurance Company was incorporated in 2005 and is based in Chennai, India.